Literature DB >> 23392234

[A 44-year-old woman with hereditary nonpolyposis colon carcinoma: screening examinations for non-colonic tumors].

J Holzhüter1, T Rösch, A Block, A W Lohse, S Lüth.   

Abstract

A 44-year-old woman presented in March 2010 for surveillance esophagogastroduodenoscopy (EGD). In October 2004, rectal cancer had been diagnosed and treated by resection of the rectum with adjuvant chemotherapy. A diagnosis of hereditary nonpolyposis colon carcinoma (HNPCC) was established on the basis of the Amsterdam II criteria. Due to a lack of clear guidelines we decided to perform annual systematic surveillance examinations of the stomach and the most frequent tumor manifestations. Until 2009, extracolonic tumors were not observed in the patient. In March 2010, EGD showed a discrete erosive lesion in the gastric antrum, which was biopsied. Most notably, the histopathological examination revealed a poorly differentiated mucinous adenocarcinoma. Due to the poor differentiation, we decided against technically possible, endoscopic resection. The patient underwent subtotal gastrectomy and is still doing fine 28 months after surgery. This case prompted us to evaluate our surveillance approach in HNPCC patients and to review the literature.

Entities:  

Mesh:

Year:  2013        PMID: 23392234     DOI: 10.1007/s00108-012-3224-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  10 in total

Review 1.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

Authors:  Stuart R Cairns; John H Scholefield; Robert J Steele; Malcolm G Dunlop; Huw J W Thomas; Gareth D Evans; Jayne A Eaden; Matthew D Rutter; Wendy P Atkin; Brian P Saunders; Anneke Lucassen; Paul Jenkins; Peter D Fairclough; Christopher R J Woodhouse
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

2.  Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome.

Authors:  Louise Klarskov; Susanne Holck; Inge Bernstein; Mef Nilbert
Journal:  J Clin Pathol       Date:  2012-01-28       Impact factor: 3.411

3.  Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium.

Authors:  Timm Goecke; Karsten Schulmann; Christoph Engel; Elke Holinski-Feder; Constanze Pagenstecher; Hans K Schackert; Matthias Kloor; Erdmute Kunstmann; Holger Vogelsang; Gisela Keller; Wolfgang Dietmaier; Elisabeth Mangold; Nicolaus Friedrichs; Peter Propping; Stefan Krüger; Johannes Gebert; Wolff Schmiegel; Josef Rueschoff; Markus Loeffler; Gabriela Moeslein
Journal:  J Clin Oncol       Date:  2006-08-14       Impact factor: 44.544

4.  Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.

Authors:  Noralane M Lindor; Kari Rabe; Gloria M Petersen; Robert Haile; Graham Casey; John Baron; Steve Gallinger; Bharati Bapat; Melyssa Aronson; John Hopper; Jeremy Jass; Loic LeMarchand; John Grove; John Potter; Polly Newcomb; Jonathan P Terdiman; Peggy Conrad; Gabriella Moslein; Richard Goldberg; Argyrios Ziogas; Hoda Anton-Culver; Mariza de Andrade; Kim Siegmund; Stephen N Thibodeau; Lisa A Boardman; Daniela Seminara
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

Review 5.  Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.

Authors:  Noralane M Lindor; Gloria M Petersen; Donald W Hadley; Anita Y Kinney; Susan Miesfeldt; Karen H Lu; Patrick Lynch; Wylie Burke; Nancy Press
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

6.  MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.

Authors:  H F Vasen; A Stormorken; F H Menko; F M Nagengast; J H Kleibeuker; G Griffioen; B G Taal; P Moller; J T Wijnen
Journal:  J Clin Oncol       Date:  2001-10-15       Impact factor: 44.544

7.  Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.

Authors:  Lisette G Capelle; Nicole C T Van Grieken; Hester F Lingsma; Ewout W Steyerberg; Willem J Klokman; Marco J Bruno; Hans F A Vasen; Ernst J Kuipers
Journal:  Gastroenterology       Date:  2009-11-10       Impact factor: 22.682

Review 8.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.

Authors:  H T Lynch; P M Lynch; S J Lanspa; C L Snyder; J F Lynch; C R Boland
Journal:  Clin Genet       Date:  2009-07       Impact factor: 4.438

Review 9.  Management of extracolonic tumours in patients with Lynch syndrome.

Authors:  Jan J Koornstra; Marian Je Mourits; Rolf H Sijmons; Annemarie M Leliveld; Harry Hollema; Jan H Kleibeuker
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

Review 10.  Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

Authors:  H F A Vasen; G Möslein; A Alonso; I Bernstein; L Bertario; I Blanco; J Burn; G Capella; C Engel; I Frayling; W Friedl; F J Hes; S Hodgson; J-P Mecklin; P Møller; F Nagengast; Y Parc; L Renkonen-Sinisalo; J R Sampson; A Stormorken; J Wijnen
Journal:  J Med Genet       Date:  2007-02-27       Impact factor: 6.318

  10 in total
  1 in total

1.  Clinical significance of mismatch repair gene expression in sporadic colorectal cancer.

Authors:  Zhenqiang Sun; Xianbo Yu; Haijiang Wang; Shuo Zhang; Zeliang Zhao; Ruiwei Xu
Journal:  Exp Ther Med       Date:  2014-08-22       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.